Robert Gussin
Director/Board Member chez CASSAVA SCIENCES, INC.
Fortune : 258 495 $ au 31/03/2024
Profil
Robert Z.
Gussin is currently an Independent Director at Cassava Sciences, Inc. and a Director at Duquesne University of The Holy Spirit.
He was previously a Director at Locus Pharmaceuticals, Inc., CHRISTUS Health, Inc., and Principal at Lederle Laboratories.
He also served as Chief Scientific Officer and VP-Science & Technology at Johnson & Johnson and VP-Research, Development & Scientific Affairs at McNeil-PPC, Inc. Dr. Gussin holds undergraduate, graduate, and doctorate degrees from Duquesne University of The Holy Spirit and a doctorate degree from the University of Michigan.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CASSAVA SCIENCES, INC.
0,03% | 19/03/2024 | 12 740 ( 0,03% ) | 258 495 $ | 31/03/2024 |
Postes actifs de Robert Gussin
| Sociétés | Poste | Début |
|---|---|---|
| CASSAVA SCIENCES, INC. | Director/Board Member | 01/03/2003 |
| Duquesne University of The Holy Spirit | Director/Board Member | - |
Anciens postes connus de Robert Gussin
| Sociétés | Poste | Fin |
|---|---|---|
CHRISTUS Health, Inc.
 CHRISTUS Health, Inc. Miscellaneous Commercial ServicesCommercial Services CHRISTUS Health, Inc. owns and operates hospitals and health care facilities. It offers its services in Texas, Arkansas, Iowa, Louisiana, Missouri, Georgia, New Mexico, and Mexico. The company was founded in 1999 and is headquartered in Irving, TX. | Director/Board Member | 01/01/2009 |
| JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | 01/01/2000 |
Lederle Laboratories
 Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a private company that provides testing services. The company is based in Pearl River, NY. | Corporate Officer/Principal | 01/01/1974 |
McNeil-PPC, Inc.
 McNeil-PPC, Inc. Pharmaceuticals: MajorHealth Technology McNeil-PPC, Inc. manufactures pharmaceutical and personal care products. The company was founded on December 30, 1988 and is headquartered in Fort Washington, PA. | Chief Tech/Sci/R&D Officer | - |
Locus Pharmaceuticals, Inc.
 Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Director/Board Member | - |
Formation de Robert Gussin
| Duquesne University of The Holy Spirit | Doctorate Degree |
| University of Michigan | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| CASSAVA SCIENCES, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Locus Pharmaceuticals, Inc.
Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Health Technology |
CHRISTUS Health, Inc.
CHRISTUS Health, Inc. Miscellaneous Commercial ServicesCommercial Services CHRISTUS Health, Inc. owns and operates hospitals and health care facilities. It offers its services in Texas, Arkansas, Iowa, Louisiana, Missouri, Georgia, New Mexico, and Mexico. The company was founded in 1999 and is headquartered in Irving, TX. | Commercial Services |
McNeil-PPC, Inc.
McNeil-PPC, Inc. Pharmaceuticals: MajorHealth Technology McNeil-PPC, Inc. manufactures pharmaceutical and personal care products. The company was founded on December 30, 1988 and is headquartered in Fort Washington, PA. | Health Technology |
Lederle Laboratories
Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a private company that provides testing services. The company is based in Pearl River, NY. | Commercial Services |
